Loading…

Protective Effect of Sulforaphane against Dopaminergic Cell Death

Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have pr...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 2007-04, Vol.321 (1), p.249-256
Main Authors: Han, Ji Man, Lee, Yong Jin, Lee, So Yeon, Kim, Eun Mee, Moon, Younghye, Kim, Ha Won, Hwang, Onyou
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3
cites cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3
container_end_page 256
container_issue 1
container_start_page 249
container_title The Journal of pharmacology and experimental therapeutics
container_volume 321
creator Han, Ji Man
Lee, Yong Jin
Lee, So Yeon
Kim, Eun Mee
Moon, Younghye
Kim, Ha Won
Hwang, Onyou
description Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase (QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or prevention of PD.
doi_str_mv 10.1124/jpet.106.110866
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1124_jpet_106_110866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17259450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</originalsourceid><addsrcrecordid>eNpFkM1Lw0AQxRdRbK2evUlO3mJndpNtcixt_YCCgnpe9jNJSbphkyr9701JwdPMG35v4D1C7hGeEGky37W2f0Lgg4KM8wsyxZRiDAjskkwBKI1ZytMJuem6HQAmCWfXZIILmuZJClOy_Ai-t7qvfmy0cW7YIu-iz0PtfJBtKfc2koWs9l0frX0rm2pvQ1HpaGXrOlpb2Ze35MrJurN35zkj38-br9VrvH1_eVstt7FmOe1jTTPIEpkxJR23CJonxjC0ariYBULKLc-oyQ1Vucul0kaj4QhKZRlQptiMzMe_OviuC9aJNlSNDEeBIE5liFMZg-BiLGNwPIyO9qAaa_75c_oBeByBsirK3ypYMSQOjdS-9sVRMIoCBU1y9gc4V2iM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><source>Freely Accessible Journals</source><creator>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</creator><creatorcontrib>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</creatorcontrib><description>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase (QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or prevention of PD.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1124/jpet.106.110866</identifier><identifier>PMID: 17259450</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Biopterins - analogs &amp; derivatives ; Biopterins - antagonists &amp; inhibitors ; Biopterins - pharmacology ; Cell Death - drug effects ; Cell Membrane - drug effects ; Cell Membrane - ultrastructure ; Cells, Cultured ; Chromosomes - drug effects ; DNA Fragmentation - drug effects ; Dopamine - physiology ; Humans ; Immunohistochemistry ; Isothiocyanates ; L-Lactate Dehydrogenase - metabolism ; Oxidopamine - pharmacology ; Quinones - pharmacology ; Reactive Oxygen Species - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Sulfoxides ; Thiocyanates - pharmacology</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.249-256</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</citedby><cites>FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17259450$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Ji Man</creatorcontrib><creatorcontrib>Lee, Yong Jin</creatorcontrib><creatorcontrib>Lee, So Yeon</creatorcontrib><creatorcontrib>Kim, Eun Mee</creatorcontrib><creatorcontrib>Moon, Younghye</creatorcontrib><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Hwang, Onyou</creatorcontrib><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase (QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or prevention of PD.</description><subject>Biopterins - analogs &amp; derivatives</subject><subject>Biopterins - antagonists &amp; inhibitors</subject><subject>Biopterins - pharmacology</subject><subject>Cell Death - drug effects</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - ultrastructure</subject><subject>Cells, Cultured</subject><subject>Chromosomes - drug effects</subject><subject>DNA Fragmentation - drug effects</subject><subject>Dopamine - physiology</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Isothiocyanates</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Oxidopamine - pharmacology</subject><subject>Quinones - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Sulfoxides</subject><subject>Thiocyanates - pharmacology</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpFkM1Lw0AQxRdRbK2evUlO3mJndpNtcixt_YCCgnpe9jNJSbphkyr9701JwdPMG35v4D1C7hGeEGky37W2f0Lgg4KM8wsyxZRiDAjskkwBKI1ZytMJuem6HQAmCWfXZIILmuZJClOy_Ai-t7qvfmy0cW7YIu-iz0PtfJBtKfc2koWs9l0frX0rm2pvQ1HpaGXrOlpb2Ze35MrJurN35zkj38-br9VrvH1_eVstt7FmOe1jTTPIEpkxJR23CJonxjC0ariYBULKLc-oyQ1Vucul0kaj4QhKZRlQptiMzMe_OviuC9aJNlSNDEeBIE5liFMZg-BiLGNwPIyO9qAaa_75c_oBeByBsirK3ypYMSQOjdS-9sVRMIoCBU1y9gc4V2iM</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Han, Ji Man</creator><creator>Lee, Yong Jin</creator><creator>Lee, So Yeon</creator><creator>Kim, Eun Mee</creator><creator>Moon, Younghye</creator><creator>Kim, Ha Won</creator><creator>Hwang, Onyou</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20070401</creationdate><title>Protective Effect of Sulforaphane against Dopaminergic Cell Death</title><author>Han, Ji Man ; Lee, Yong Jin ; Lee, So Yeon ; Kim, Eun Mee ; Moon, Younghye ; Kim, Ha Won ; Hwang, Onyou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biopterins - analogs &amp; derivatives</topic><topic>Biopterins - antagonists &amp; inhibitors</topic><topic>Biopterins - pharmacology</topic><topic>Cell Death - drug effects</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - ultrastructure</topic><topic>Cells, Cultured</topic><topic>Chromosomes - drug effects</topic><topic>DNA Fragmentation - drug effects</topic><topic>Dopamine - physiology</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Isothiocyanates</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Oxidopamine - pharmacology</topic><topic>Quinones - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Sulfoxides</topic><topic>Thiocyanates - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Ji Man</creatorcontrib><creatorcontrib>Lee, Yong Jin</creatorcontrib><creatorcontrib>Lee, So Yeon</creatorcontrib><creatorcontrib>Kim, Eun Mee</creatorcontrib><creatorcontrib>Moon, Younghye</creatorcontrib><creatorcontrib>Kim, Ha Won</creatorcontrib><creatorcontrib>Hwang, Onyou</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Ji Man</au><au>Lee, Yong Jin</au><au>Lee, So Yeon</au><au>Kim, Eun Mee</au><au>Moon, Younghye</au><au>Kim, Ha Won</au><au>Hwang, Onyou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protective Effect of Sulforaphane against Dopaminergic Cell Death</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>321</volume><issue>1</issue><spage>249</spage><epage>256</epage><pages>249-256</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>Parkinson's disease (PD) is a progressive neurodegenerative disorder with a selective loss of dopaminergic neurons in the substantia nigra. Evidence suggests oxidation of dopamine (DA) to DA quinone and consequent oxidative stress as a major factor contributing to this vulnerability. We have previously observed that exposure to or induction of NAD(P)H:quinone reductase (QR1), the enzyme that catalyzes the reduction of quinone, effectively protects DA cells. Sulforaphane (SF) is a drug identified as a potent inducer of QR1 in various non-neuronal cells. In the present study, we show that SF protects against compounds known to induce DA quinone production (6-hydroxydopamine and tetrahydrobiopterin) in DAergic cell lines CATH.a and SK-N-BE(2)C as well as in mesencephalic DAergic neurons. SF leads to attenuation of the increase in protein-bound quinone in tetrahydrobiopterin-treated cells, but this does not occur in cells that have been depleted of DA, suggesting involvement of DA quinone. SF pretreatment prevents membrane damage, DNA fragmentation, and accumulation of reactive oxygen species. SF causes increases in mRNA levels and enzymatic activity of QR1 in a dose-dependent manner. Taken together, these results indicate that SF causes induction of QR1 gene expression, removal of intracellular DA quinone, and protection against toxicity in DAergic cells. Thus, this major isothiocyanate found in cruciferous vegetables may serve as a potential candidate for development of treatment and/or prevention of PD.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>17259450</pmid><doi>10.1124/jpet.106.110866</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.249-256
issn 0022-3565
1521-0103
language eng
recordid cdi_crossref_primary_10_1124_jpet_106_110866
source Freely Accessible Journals
subjects Biopterins - analogs & derivatives
Biopterins - antagonists & inhibitors
Biopterins - pharmacology
Cell Death - drug effects
Cell Membrane - drug effects
Cell Membrane - ultrastructure
Cells, Cultured
Chromosomes - drug effects
DNA Fragmentation - drug effects
Dopamine - physiology
Humans
Immunohistochemistry
Isothiocyanates
L-Lactate Dehydrogenase - metabolism
Oxidopamine - pharmacology
Quinones - pharmacology
Reactive Oxygen Species - metabolism
Reverse Transcriptase Polymerase Chain Reaction
Sulfoxides
Thiocyanates - pharmacology
title Protective Effect of Sulforaphane against Dopaminergic Cell Death
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A50%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protective%20Effect%20of%20Sulforaphane%20against%20Dopaminergic%20Cell%20Death&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Han,%20Ji%20Man&rft.date=2007-04-01&rft.volume=321&rft.issue=1&rft.spage=249&rft.epage=256&rft.pages=249-256&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1124/jpet.106.110866&rft_dat=%3Cpubmed_cross%3E17259450%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-c28084a83baf6e10c64dd31eb83bd71056e682d9d2b9f9abcdc1d610bb88023b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/17259450&rfr_iscdi=true